Inavolisib

Inavolisib is a small molecule inhibitor of phosphatidylinositol 3-kinase and is used in combination with other antineoplastic agents to treat selected adults with locally advanced or metastatic breast cancer. Inavolisib is associated with transient elevations in serum aminotransferase levels during therapy but has not been linked to episodes of clinically apparent liver injury with jaundice. The directory classifies it as a commercial API with a biotechnology source/manufacturing origin. Other names for this substance include Itovebi and GDC-0077. Its PubChem CID is 124173720.

CAS No 2060571-02-8
Molecular Formula C18H19F2N5O4
Molecular Weight 407.4 g/mol
Synonyms (2S)-2-[[2-[(4S)-4-(difluoromethyl)-2-oxo-1,3-oxazolidin-3-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl]amino]propanamide

Frequently Asked Questions